Crohn Disease

5 competing products in clinical development for Crohn Disease.

Pipeline by Phase

Pre-clinical2
Phase 22
Approved1

All Products (5)

ProductCompanyStageStatusHype
LY4395089 + Mirikizumab - Intravenous (IV) + Mirikizumab - Subcutaneous (SC)Eli LillyPhase 2Recruiting
42
Infliximab CT-P13 + Immunosuppressors (Thiopurines or Methotrexate)CelltrionApprovedUNKNOWN
39
Ustekinumab 45 mg + Ustekinumab 90 mgCelltrionPre-clinicalRecruiting
33
UstekinumabSun PharmaceuticalPre-clinicalRecruiting
33
VTX958 + VTX958 + VTX958 PlaceboVentyx BiosciencesPhase 2Terminated
21